Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme
NCT ID: NCT06696534
Last Updated: 2025-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1000 participants
INTERVENTIONAL
2025-05-19
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Values of experience of participants into screening programme.
* Values of preferences of participants for screening methods.
Participants will answer two questionnaires and they'll be given their information and clinical data to investigator or health personnel.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection
NCT06703632
Observational Cross-reactivity Study for Colorectal Cancer Diagnosis
NCT06889844
CRC Screening in Unscreened Individuals 45-54
NCT06757192
Colorectal Cancer Screening for Cancer Survivors
NCT00982059
Colorectal Cancer: Screening vs. Non-Screening
NCT02727894
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FIT/FOBT population
Average-risk population undergoing FIT/FOBT within the colorectal cancer screening programme.
Survey using a questionnaire.
Preference questionnaire for colorectal cancer screening methods
Survey using a questionnaire.
Experience questionnaire into colorectal cancer screening programme
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survey using a questionnaire.
Preference questionnaire for colorectal cancer screening methods
Survey using a questionnaire.
Experience questionnaire into colorectal cancer screening programme
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants invited to participate in population-based screening programme who are eligible to undertake FOBT at the Primary Health Care Center.
* Participants should sign an informed consent. They must understand the nature, significance, implications, and risks of the clinical study before signing the informed consent form.
Exclusion Criteria
* Participants with a previous colonoscopy in consequence of a FOBT positive result.
* Participants who are in a dependent personal or non-medical relationship with the Sponsor or the Investigators.
50 Years
69 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SERMAS
UNKNOWN
ULS de Santa Maria
UNKNOWN
ADVANCED MARKER DISCOVERY S.L.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria A Perez, MD
Role: PRINCIPAL_INVESTIGATOR
Primary Health Care Centre Mar Báltico
Ana Rita, MD
Role: PRINCIPAL_INVESTIGATOR
Unidade Local de Saúde de Santa Maria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCSP Sete Rios
Lisbon, , Portugal
CS Mar Báltico
Madrid, Madrid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ana Rita, MD
Role: primary
Maria A Perez, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Adler A, Geiger S, Keil A, Bias H, Schatz P, deVos T, Dhein J, Zimmermann M, Tauber R, Wiedenmann B. Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany. BMC Gastroenterol. 2014 Oct 17;14:183. doi: 10.1186/1471-230X-14-183.
De Angelis R, Demuru E, Baili P, Troussard X, Katalinic A, Chirlaque Lopez MD, Innos K, Santaquilani M, Blum M, Ventura L, Paapsi K, Galasso R, Guevara M, Randi G, Bettio M, Botta L, Guzzinati S, Dal Maso L, Rossi S; EUROCARE-6 Working Group. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study. Lancet Oncol. 2024 Mar;25(3):293-307. doi: 10.1016/S1470-2045(23)00646-0. Epub 2024 Jan 30.
Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023 May-Jun;73(3):233-254. doi: 10.3322/caac.21772. Epub 2023 Mar 1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-NDMH-5101_240046
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
AMD-CCR-2024-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.